EQUIVIRT: Study of Balance Reactions in a Virtual Environment Compared to a Real Environment

Sponsor
Pôle Saint Hélier (Other)
Overall Status
Completed
CT.gov ID
NCT04574726
Collaborator
Hopital La Musse (Other)
70
2
2
2.1
35
16.4

Study Details

Study Description

Brief Summary

Validate a virtual environment by demonstrating a non modification of the characteristics of postural reaction and displacement of the body's center of pressure between a real environment and the same environment in immersive virtual reality.

Condition or Disease Intervention/Treatment Phase
  • Other: static balance
  • Other: dynamic balance
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
70 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Intervention Model Description:
Prospective, multicenter, controlled, randomized, intervention study with minimal risks and constraints (RIPH2) on healthy volunteers.Prospective, multicenter, controlled, randomized, intervention study with minimal risks and constraints (RIPH2) on healthy volunteers.
Masking:
None (Open Label)
Primary Purpose:
Screening
Official Title:
Study of Balance Reactions in a Virtual Environment Compared to a Real Environment
Actual Study Start Date :
Nov 16, 2020
Actual Primary Completion Date :
Jan 20, 2021
Actual Study Completion Date :
Jan 20, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: virtual environment

Balance test in virtual environment with a virtual reality software executed in a 6DOF Occulus Quest helmet and a motion capture software with a Kinect Azure DK camera.

Other: static balance
30-second right and left unipodal static balance test

Other: dynamic balance
for the unipodal dynamic balance test, 4 movements will be done by the volunteers in this order : 180° elevation of the arms lowering of the arms on the side of the single-legged support to the horizontal position 180° horizontal translation of the arms return from the horizontal to the starting point

Active Comparator: reel environment

Balance test in real environment with a motion capture software and a Kinect Azure DK camera.

Other: static balance
30-second right and left unipodal static balance test

Other: dynamic balance
for the unipodal dynamic balance test, 4 movements will be done by the volunteers in this order : 180° elevation of the arms lowering of the arms on the side of the single-legged support to the horizontal position 180° horizontal translation of the arms return from the horizontal to the starting point

Outcome Measures

Primary Outcome Measures

  1. Area of CoP (Center of pression) [Immediately after inclusion]

    Mesure of area of center of pression during the balance tests in virtual condition and real condition, order in terms of randomisation

Secondary Outcome Measures

  1. Total distance covered by the CoP during the balance test (in mm) [Immediately after inclusion]

    Mesure of the total distance covered by the CoP during the balance tests (in mm) in virtual condition and real condition, order in terms of randomisation

  2. Simulator Sickness Quantifying (SSQ) [Immediately after the balance test]

    SSQ completed after the balance test, SSQ is a scale of cyber sickness, from 0 to 48.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Healthy volunteer, men and women over 18 years old
Exclusion Criteria:
  • Severe visual disorders which couldn't enable immersive virtual reality experience

  • Immobilisation of one of the upper limbs (restraint splint)

  • Orthopedic problems and pain in the lower limb

  • MSSQ upper than 25

  • Pregnant women

  • Person under legal protection

Contacts and Locations

Locations

Site City State Country Postal Code
1 Pole Saint-Hélier Rennes Bretagne France 35000
2 Hôpital la Musse Saint-Sébastien-de-Morsent France 27180

Sponsors and Collaborators

  • Pôle Saint Hélier
  • Hopital La Musse

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Pôle Saint Hélier
ClinicalTrials.gov Identifier:
NCT04574726
Other Study ID Numbers:
  • 2020-A01841-38
First Posted:
Oct 5, 2020
Last Update Posted:
Jan 22, 2021
Last Verified:
Jan 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Jan 22, 2021